Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26908 | 19556219 | Arch Dis Child | A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. | 2009 | Details |
A26909 | 19556020 | J Hepatol | Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. | 2009 | Details |
A26910 | 19554810 | J Pediatr Endocrinol Metab | Can the insulin sensitivity index (ISI) in association with insulin-like growth factor binding protein-1 identify insulin resistance early in overweight children? | 2009 | Details |
A26911 | 19381126 | Ann Hepatol | Is exercise an effective treatment for NASH? Knowns and unknowns. | 2009 | Details |
A26912 | 19381125 | Ann Hepatol | Treatment regimens for non-alcoholic fatty liver disease. | 2009 | Details |
A26913 | 19381124 | Ann Hepatol | Association between type two diabetes and non-alcoholic fatty liver disease in youth. | 2009 | Details |
A26914 | 19381123 | Ann Hepatol | Nonalcoholic fatty liver disease and its association with cardiovascular disease. | 2009 | Details |
A26915 | 19381122 | Ann Hepatol | Role of nonalcoholic fatty liver disease in hepatocellular carcinoma. | 2009 | Details |
A26916 | 19381121 | Ann Hepatol | Noninvasive diagnosis of nonalcoholic fatty liver disease. | 2009 | Details |
A26917 | 19381120 | Ann Hepatol | Metabolic syndrome and non-alcoholic fatty liver disease. | 2009 | Details |
A26918 | 19381119 | Ann Hepatol | New insights into the pathophysiology of nonalcoholic fatty liver disease. | 2009 | Details |
A26919 | 19381118 | Ann Hepatol | Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
A26921 | 19546889 | Cell Res | Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. | 2009 | Details |
A26922 | 19546545 | Dig Dis | Hepatocellular carcinoma--epidemiological trends and risk factors. | 2009 | Details |
A26923 | 19542757 | J Endocrinol Invest | Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. | 2009 | Details |
A26924 | 19542081 | J Med Genet | A common variant in the adiponutrin gene influences liver enzyme values. | 2009 | Details |
A26925 | 19541928 | Am J Pathol | High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. | 2009 | Details |
A26926 | 19536316 | Ther Clin Risk Manag | Fatty liver in children. | 2009 | Details |
A26927 | 19533014 | J Gastroenterol | Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. | 2009 | Details |
A26928 | 19532130 | Am J Gastroenterol | A complex role of activin A in non-alcoholic fatty liver disease. | 2009 | Details |
A26929 | 19527485 | Hepatol Res | Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis. | 2009 | Details |
A26930 | 19525862 | J Clin Gastroenterol | Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. | 2009 | Details |
A26931 | 19525859 | J Clin Gastroenterol | Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease. | 2010 | Details |
A26932 | 19524579 | Gastroenterology | Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. | 2009 | Details |
A26933 | 19523535 | Clin Gastroenterol Hepatol | Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A26934 | 19519467 | Endocr Metab Immune Disord Drug Targets | Dissecting insulin signaling pathways: individualised therapeutic targets for diagnosis and treatment of insulin resistant states. | 2009 | Details |
A26935 | 19519352 | Curr Drug Targets | Liver fibrosis and therapeutic strategies: the goal for improving metabolism. | 2009 | Details |
A26936 | 19515391 | Med Clin (Barc) | [Non alcoholic steatosis in HIV infection]. | 2009 | Details |
A26937 | 19515216 | Liver Int | Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. | 2009 | Details |
A26938 | 19513842 | Dig Dis Sci | Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. | 2009 | Details |
A26939 | 19513120 | PLoS One | Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. | 2009 | Details |
A26940 | 19508612 | Aliment Pharmacol Ther | Predictors of health-related quality of life in patients with chronic liver disease. | 2009 | Details |
A26941 | 19502653 | Ann Hepatol | Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease. | 2009 | Details |
A26942 | 19502649 | Ann Hepatol | Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. | 2009 | Details |
A26943 | 19502161 | Hepatobiliary Pancreat Dis Int | Commonly used animal models of non-alcoholic steatohepatitis. | 2009 | Details |
A26944 | 19491838 | Am J Gastroenterol | The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. | 2009 | Details |
A26945 | 19491421 | Indian J Med Res | A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. | 2009 | Details |
A26946 | 19490416 | Liver Int | Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. | 2009 | Details |
A26947 | 19484180 | J Gastroenterol | Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. | 2009 | Details |
A26948 | 19478676 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. | 2010 | Details |
A26949 | 19476560 | J Gastroenterol Hepatol | Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. | 2009 | Details |
A26950 | 19475694 | Hepatology | Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. | 2009 | Details |
A26951 | 19474742 | Eur J Gastroenterol Hepatol | Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. | 2009 | Details |
A26952 | 19474520 | J Endocrinol Invest | UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity. | 2009 | Details |
A26953 | 19473430 | Hepatol Res | The effect of ursodeoxycholic acid on liver regeneration after partial hepatectomy in rats with non-alcoholic fatty liver disease. | 2009 | Details |
A26954 | 19472390 | J Magn Reson Imaging | Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. | 2009 | Details |
A26955 | 19466213 | Arq Bras Endocrinol Metabol | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. | 2009 | Details |
A26956 | 19464941 | Int J Med Inform | Towards application of rule learning to the meta-analysis of clinical data: an example of the metabolic syndrome. | 2009 | Details |
A26957 | 19464851 | Epilepsy Res | Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. | 2009 | Details |
A26958 | 19464748 | J Hepatol | 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. | 2009 | Details |
A26959 | 19464069 | J Hepatol | Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. | 2009 | Details |
A26960 | 19460054 | Intern Med J | Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. | 2010 | Details |
A26961 | 19459046 | Dig Dis Sci | Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. | 2009 | Details |
A26962 | 19452573 | World J Gastroenterol | Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease. | 2009 | Details |
A26963 | 19452403 | Semin Thromb Hemost | Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. | 2009 | Details |
A26964 | 19450891 | J Hepatol | Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. | 2009 | Details |
A26966 | 19447517 | J Hepatol | Kupffer cells in non-alcoholic fatty liver disease: the emerging view. | 2009 | Details |
A26967 | 19446916 | J Hepatol | Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model. | 2009 | Details |
A26968 | 19444865 | Diabetes Metab Res Rev | Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload. | 2009 | Details |
A26969 | 19444112 | Curr Opin Pediatr | The metabolic syndrome and nonalcoholic fatty liver disease in children. | 2009 | Details |
A26970 | 19443967 | Intern Med | Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. | 2009 | Details |
A26971 | 19442917 | Clin Liver Dis | Nonalcoholic fatty liver disease: a practical approach to evaluation and management. | 2009 | Details |
A26972 | 19440836 | Dig Dis Sci | Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. | 2009 | Details |
A26973 | 19437558 | World J Gastroenterol | Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. | 2009 | Details |
A26974 | 19434741 | Hepatology | Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. | 2009 | Details |
A26975 | 19427351 | Toxicology | Protective effect of bicyclol on tetracycline-induced fatty liver in mice. | 2009 | Details |
A26976 | 19424408 | Rev Gastroenterol Peru | [Non alcoholic fatty liver. A frequent entity with an unknown outcome]. | 2009 | Details |
A26977 | 19423319 | J Nutr Biochem | Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. | 2009 | Details |
A26978 | 19422483 | Liver Int | Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. | 2009 | Details |
A26979 | 19418586 | World J Gastroenterol | Hyperferritinemia is a risk factor for steatosis in chronic liver disease. | 2009 | Details |
A26980 | 19418409 | Z Gastroenterol | Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology. | 2009 | Details |
A26981 | 19416647 | Biochim Biophys Acta | Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progression of d-galactosamine-induced hepatitis in mice fed with a high-fat/high-sucrose diet. | 2009 | Details |
A26982 | 19413701 | Obes Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. | 2009 | Details |
A26983 | 19412009 | J Pediatr Gastroenterol Nutr | Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults. | 2009 | Details |
A26984 | 19412008 | J Pediatr Gastroenterol Nutr | Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. | 2009 | Details |
A26985 | 19409898 | Gastroenterology | Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. | 2009 | Details |
A26986 | 19409076 | BMC Med | The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. | 2009 | Details |
A26987 | 19408737 | Acta Gastroenterol Latinoam | [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?]. | 2009 | Details |
A26988 | 19403348 | Dig Liver Dis | Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. | 2009 | Details |
A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
A26990 | 19393338 | Biochim Biophys Acta | Lipid aldehyde-mediated cross-linking of apolipoprotein B-100 inhibits secretion from HepG2 cells. | 2009 | Details |
A26991 | 19390517 | Obesity (Silver Spring) | Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. | 2009 | Details |
A26992 | 19387108 | J Alzheimers Dis | Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. | 2009 | Details |
A26993 | 19386026 | Liver Int | Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. | 2009 | Details |
A26994 | 19378390 | J Gastroenterol Hepatol | The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. | 2009 | Details |
A26996 | 19373421 | Can J Gastroenterol | Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. | 2009 | Details |
A26997 | 19372595 | J Lipid Res | Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. | 2009 | Details |
A26998 | 19371271 | Pediatr Int | Ghrelin and leptin modulate immunity and liver function in overweight children. | 2009 | Details |
A26999 | 19370784 | World J Gastroenterol | Non-alcoholic steatohepatitis with normal aminotransferase values. | 2009 | Details |
A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
A27003 | 19367083 | J Oleo Sci | Principal component analysis of direct matrix-assisted laser desorption/ionization mass spectrometric data related to metabolites of fatty liver. | 2009 | Details |
A27004 | 19366381 | J Am Acad Nurse Pract | Fatty liver in adolescents on the U.S.-Mexico border. | 2009 | Details |
A27005 | 19363256 | J Alzheimers Dis | Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis. | 2009 | Details |
A27006 | 19362523 | Dig Liver Dis | Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. | 2009 | Details |
A27007 | 19360318 | Int J Mol Med | Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. | 2009 | Details |
A27008 | 19360277 | Rev Assoc Med Bras (1992) | [Abdominal ultrasound and magnetic resonance imaging: a comparative study on the non-alcoholic fatty liver disease diagnosis in morbidly obese patients]. | 2009 | Details |
A27009 | 19360015 | Obesity (Silver Spring) | Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. | 2009 | Details |
A27010 | 19359436 | Gut | Toll-like receptors as targets in chronic liver diseases. | 2009 | Details |
A27011 | 19359149 | Nutr Metab Cardiovasc Dis | Hepatic lipid metabolism and non-alcoholic fatty liver disease. | 2009 | Details |
A27012 | 19358839 | Eur J Pharmacol | Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats. | 2009 | Details |